Related Experiment Video
Updated: Jul 4, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Current Concepts in Perioperative Guidance and Outcomes in Hand Surgery Patients Taking Glucagon-Like Peptide-1
Ethan Y Song1, M Stephen Melton2, Warren Hammert3
1Division of Plastic, Oral, and Maxillofacial Surgery, Department of Surgery, Duke University School of Medicine, Durham, NC.
Abstract:
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide and tirzepatide, have rapidly increased in use for diabetes management and weight loss, coinciding with the rising prevalence of obesity and diabetes among patients undergoing hand surgery. Growing perioperative concerns of delayed gastric emptying and aspiration risk have prompted evolving guideline recommendations and clinical uncertainty surrounding surgical planning. Current evidence on GLP-1 RA usage and outcomes in hand and orthopedic literature remains limited, but multiple studies report no notable increase in postoperative complications. There may be potential benefits to GLP-1 RA in surgical outcomes, possibly related to reduced systemic medical morbidity and improved metabolic control. As there still are substantial limitations in the medical literature on the effects of GLP-1 RA, questions remain regarding optimal perioperative medication management, effects on bone and wound healing in the context of rapid weight loss, and anesthesia-related risk. Yet, as GLP-1 RA exposure becomes increasingly common, hand surgeons must understand the pharmacology, risk profile, and emerging evidence to guide individualized decision-making and ensure safe perioperative management for patients.
Related Concept Videos
Hypoglycemia and Glucagon
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Oral Hypoglycemic Agents: Glinides
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Peripheral Artery Disease V: Postoperative Nursing Management